|
Market Closed -
Nasdaq
20:00:00 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 14.74 USD | +1.66% |
|
-0.81% | -4.47% |
| 09-30 | Jade Biosciences, Inc. - Special Call | |
| 09-30 | Jade Biosciences, Inc. Announces Preclinical Data Characterizing Jade301 | CI |
Company Valuation: Jade Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 709.8 | 937.4 | - | - |
| Change | - | 32.06% | - | - |
| Enterprise Value (EV) 1 | 373.7 | 591.7 | 583.7 | 601.6 |
| Change | - | 58.35% | -1.36% | 3.06% |
| P/E | -4.84x | -5.05x | -5.14x | -5.18x |
| PBR | - | 3.43x | 7.36x | 4.09x |
| PEG | -0.2x | 0.6x | 2.94x | 6.03x |
| Capitalization / Revenue | - | - | - | - |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | - | -2.64x | -2.51x | -2.5x |
| EV / EBIT | -3.29x | -2.78x | -2.47x | -2.3x |
| EV / FCF | -3.94x | -3.45x | -2.49x | -2.38x |
| FCF Yield | -25.4% | -29% | -40.1% | -42% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -3.19 | -2.92 | -2.869 | -2.845 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | - | - | - |
| EBITDA 1 | - | -224.4 | -232.3 | -240.4 |
| EBIT 1 | -113.5 | -212.7 | -236.8 | -261.7 |
| Net income 1 | -127.4 | -204.2 | -231.1 | -258.9 |
| Net Debt 1 | -336.2 | -345.7 | -353.7 | -335.9 |
| Reference price 2 | 15.43 | 14.74 | 14.74 | 14.74 |
| Nbr of stocks (in thousands) | 46,004 | 63,597 | - | - |
| Announcement Date | 06/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.05x | - | -2.64x | - | 937M | |
| 17.08x | 6.33x | 12.4x | 1.75% | 63.48B | |
| 30.03x | 7.96x | 26.08x | 0.05% | 54.55B | |
| 37.03x | 6.57x | 19.63x | 0.87% | 53.59B | |
| 35.05x | 3.37x | 14.55x | -.--% | 44.75B | |
| 48.28x | 5.55x | 30.42x | -.--% | 41.62B | |
| -19.33x | 186.93x | -20.57x | -.--% | 39.91B | |
| 30.28x | 7.94x | 20.6x | 0.4% | 32.47B | |
| 36.51x | 6.64x | 22.27x | -.--% | 26.7B | |
| 26.96x | 5.67x | 14.71x | -.--% | 23.36B | |
| Average | 23.68x | 26.33x | 13.74x | 0.34% | 38.14B | |
| Weighted average by Cap. | 26.47x | 25.23x | 15.63x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- JBIO Stock
- Valuation Jade Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
